Skip to main content
SpringerLink
Log in

Applications

  • Chapter
  • First Online:
The EuroQol Group after 25 years

  • 431 Accesses

Abstract

This chapter covers a range of topics rather loosely described by the term ‘applications. It covers applications of EQ-5D presented at Plenary meetings to different diseases and conditions, in different medical settings, and in the context of socio-economic inequalities. The work of the Disease Areas and Condition-Specific task forces is described, especially in the context of reviews of EQ-5D use. The chapter concludes with detailed data on: papers and posters at Plenary meetings, clinical areas, programmes, and settings.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alli M, Ibrahim M, Lawrence D, Lockhart J, Laitner S, Brogan C. Survey on tackling health inequalities amongst older people in Brent and Harrow district of the UK: results from EQ-5D questionnaire. In Macran and Kind (2002).

    Google Scholar 

  • Angelsen V and Olsen J. QALY-league tables for a hospital. In O’Hanlon and Buxton (1995).

    Google Scholar 

  • Attema A, Versteegh M, Oppe M, Brouwer W, Stolk E. Lead time TTO: leading to better health state valuations? In Yfantopoulos (2010).

    Google Scholar 

  • Badia X. (Ed.) 25th Scientific Plenary Meeting of the EuroQol Group, September 2006, Barcelona. IMS Health Barcelona, 2007.

    Google Scholar 

  • Badia X, Herdman M, Segura A. (Eds.). EuroQol Plenary Meeting Barcelona October 1995. Institut Universitari de Salut Pública de Catalunya, 1996.

    Google Scholar 

  • Badia X, Herdman M, Roset M. (Eds.). 16th Plenary Meeting of the EuroQol Group Discussion Papers, Sitges, Spain, November 1999. Institut Universitari de Salut Pública de Catalunya, 2000.

    Google Scholar 

  • Bereza BG, Machado M, Einarson TR. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder. Clinical Therapeutics 2009;31:1279–308.

    Article  PubMed  Google Scholar 

  • Betegón L and Badia X. Discussion paper review of the use of the EQ-5D in cost-utility analysis. In Badia (2007).

    Google Scholar 

  • Brooks R, Rabin R, de Charro F. The Measurement and Valuation of Health Status using EQ-5D: A European Perspective. Kluwer. 2003.

    Google Scholar 

  • Busschbach Jv. De Validiteit van QALYs. Gouda Quint, Arnhem, 1994.

    Google Scholar 

  • Busschbach J, Rabin R, de Charro F. (Eds.) 24th Scientific Plenary Meeting of the EuroQol Group Proceedings, Kijkduin–The Hague, the Netherlands, September 2007. EuroQol Group Executive Office, 2007.

    Google Scholar 

  • Cabasés J, Gaminde I, Ugalde J, Pozo F. Social elicitation of EQ-5D health states preferences through person Trade off (PTO). In Cabasés and Gaminde (2001).

    Google Scholar 

  • Cadenas E, Perulero N, Lizán L, Badia X. The use of the EQ-5D in patients with osteoporosis. In Badia (2007).

    Google Scholar 

  • Clayson D, Wild D, Quarterman P, Duprat-Lomon I, Kubin M, Coons S. A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials. Pharmacoeconomics 2006; 24:751–65.

    Article  PubMed  Google Scholar 

  • de Haan R, Aaronson N, Limburg M, Hewer R, van Crevel H. Measuring quality of life in stroke. Stroke 1993; 24:320–7.

    Article  PubMed  Google Scholar 

  • de Pouvourville G. (Ed.) 26th Scientific Plenary Meeting of the EuroQol Group Proceedings, Paris, France, September 2009. EuroQol Group Executive Office, 2009.

    Google Scholar 

  • de Wit A, Merkus M, de Charro F. Measuring utilities in an end-stage renal disease population. In Badia et al (1996).

    Google Scholar 

  • Derrett S, Black J, Herbison G. Outcome after injury: a systematic literature search of studies using the EQ-5D. Journal of Trauma 2009; 67:883–90.

    Article  PubMed  Google Scholar 

  • Derrett S, Black J, Herbison G. EQ-5D and injury: a systematic review. In Scalone and Mantovani (2008).

    Google Scholar 

  • Devlin N, Parkin D, Browne J. Using the EQ-5D as a performance measurement tool in the NHS. In Scalone and Mantovani (2008).

    Google Scholar 

  • Dyer M, Goldsmith K, Sharples L, Buxton M. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health and Quality of Life Outcomes. 2010; 28; 8:13.

    Google Scholar 

  • Elliott V, Rodgers D, Brett S. Systematic review of quality of life and other patient-centred outcomes after cardiac arrest survival. Resuscitation 2011; 82:247–56.

    Article  PubMed  Google Scholar 

  • Gharagebakyan G, Ghukasyan H, Williams A, Szende A. Social inequalities in self-reported health: is Armenia different from Slovenia? In Prevolnik Rupel (2003).

    Google Scholar 

  • Greiner W, Graf v.d. Schulenberg J-M, Piercy J. (Eds.) EuroQol Plenary Meeting Hannover October 1998 Discussion Papers. Uni-Verlag Witte, 1999.

    Google Scholar 

  • Gudex C and MacDonagh R. Change in reported health status following urological surgery: preliminary results. In Busschbach et al (1994).

    Google Scholar 

  • Hare J, Leese B, Hardman G. Applications of EuroQol (EQ5D) in general practice: an exploratory study. In Rabin et al (1998).

    Google Scholar 

  • Janssen M, Busschbach J, Golicki D, Niewada M, Scalone L, Swinburn P, Pickard AS. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in 8 patient groups. Paper presented at the 28th Scientific Plenary Meeting of the EuroQol Group, Oxford, September 2011.

    Google Scholar 

  • Janssen M, Lubetkin E, Pickard AS. The use of the EQ-5D preference-based health status measure in adults with type 2 diabetes mellitus. In de Pouvourville (2009).

    Google Scholar 

  • Jelsma J and Matyida N. The development of an adapted version of the EQ-5D for infants under the age of 36 months. In Prevolnik Rupel (2003).

    Google Scholar 

  • Kind P. In Memoriam: Alan Williams (1928−2005). Value in Health 2005c; 8: 615–617.

    Article  Google Scholar 

  • Kind P and Macran S. Levelling the playing field: increasing the number of response categories in EQ-5D. In Kind and Macran, 2002b.

    Google Scholar 

  • Kind P, Leese B, Hardman G. Demonstrating the value of EQ-5D as a tool for monitoring health status in primary care. In Rabin et al (1998).

    Google Scholar 

  • Leese B, Kind P, Hardman G. Measuring outcomes – managing performance: roles for EQ-5D in delivering primary health care services? In Macran and Kind (2002).

    Google Scholar 

  • Lloyd A, Swinburn P, Edson E, Bowman L, Boye K, Janssen M, Pickard AS, de Charro F. Development of the EQ-5D-Psoriasis. In Yfantopoulos (2010).

    Google Scholar 

  • Macran S and Kind P. An Illness Atlas for EQ-5D. In Stavem (2005).

    Google Scholar 

  • Manninen M, Ohinmaa A, Winblad I, Remes A, Viramo P, Liuska E, Hynninen, M. Health-related quality of life of care-givers of dementia patients. In Prevolnik Rupel (2003).

    Google Scholar 

  • McLernon D, Dillon J, Donnan P. Health-state utilities in liver disease: a systematic review. Medical Decision Making 2008; 28:582–92.

    Article  PubMed  Google Scholar 

  • Meyer-Moock S, Moock J, Hessel F, Kohlmann T. Awareness, relevance and potential use of the EQ-5D in German health care decision making processes. In Yfantopoulos (2010).

    Google Scholar 

  • Mills T, Law S, Walt J, Buchholz P, Hansen J. Quality of life in glaucoma and three other chronic diseases: a systematic literature review. Journal of Drugs and Aging 2009; 26:933–50.

    Article  Google Scholar 

  • Moock J and Kohlmann T. Comparing the EQ-5D, SF-6D, HU12, QWB-SA and 15D: Which measure can be recommended for use in the German system of medical rehabilitation? In Pickard (2004).

    Google Scholar 

  • Norinder A and Krabbe P. On the relationship between trade-off and scaling techniques for the valuation of health states. In Norinder et al (2002).

    Google Scholar 

  • Noyes J, Edwards RT. EQ-5D for the assessment of health-related quality of life and resource allocation in children: a systematic methodological review. Value in Health 2011;14:1117–29.

    Article  PubMed  CAS  Google Scholar 

  • Nuria L, Badia X, Montse R, Nuria P, Noelia B, Neus C. Use of the Spanish version of the EQ-5D in different disease areas and population sub-groups. In Stavem (2005).

    Google Scholar 

  • O’Hanlon M and Buxton M. (Eds.) EuroQol Plenary meeting London October 1994 Conference Proceedings. Health Economics Research Group, Brunel University, 1995.

    Google Scholar 

  • Oppe M, Szende A, de Charro F. Development of a methodology to gain insight on the use of EQ-5D in different disease areas. In Stavem (2005).

    Google Scholar 

  • Papaioannou D, Brazier J, Parry G How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review. Value in Health 2011;14:907–20.

    Article  PubMed  Google Scholar 

  • Parkin D, Rice A, Jacoby A. Use of the EQ VAS in a daily patient diary. In Badia et al (2000).

    Google Scholar 

  • Pickard AS. (Ed.) 21st Scientific Plenary Meeting of the EuroQol Group Discussion Papers, September 2004, Chicago, USA. Center for Pharmacoeconomics Research, University of Illinois, Chicago, 2004.

    Google Scholar 

  • Pickard AS and Lin F. Is EQ-5D inferior in content to disease-specific utility measures? In Yfantopoulos (2010).

    Google Scholar 

  • Pickard AS, De Leon M, Kohlmann T, Cella D, Rosenbloom S. Psychometric comparison of the standard EQ-5D to a 5-level version in cancer patients. In Badia (2007a).

    Google Scholar 

  • Pickard AS, Wilke C, Hsiang-Wen L, Lloyd A. Impact of cancer on health related quality of life: evidence using the EQ-5D. In Badia et al (2007c).

    Google Scholar 

  • Pickard AS, Wilke C, Jung E, Patel S, Stavem K, Lee T. Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respiratory Medicine 2008;102:519–36.

    Article  PubMed  Google Scholar 

  • Pickard AS, Wilke C, Jung E. Patel S, Stavem K, Lee T. Use of a preference-based measure of health (EQ-5D) in COPD and asthma. In Busschbach (2007d).

    Google Scholar 

  • Pickard AS, Wilke C, Lin H, Lloyd A. Health utilities using the EQ-5D in studies of cancer. Pharmacoeconomics 2007e; 25:365–84.

    Article  PubMed  Google Scholar 

  • Prevolnik Rupel V. (Ed.) 20th Plenary Meeting of the EuroQol Group Discussion Papers, Bled, Slovenija, September, 2003. Republic of Slovenia Ministry of Health, 2003.

    Google Scholar 

  • Rabin R, Busschbach Jv, de Charro F, Essink-Bot M-L, Bonsel G. (Eds.) EuroQol Plenary Meeting, Rotterdam, October 1997 Discussion Papers. Institute for Medical Technology Assessment, 1998.

    Google Scholar 

  • Rebolj M and Prevolnik Rupel V. Socioeconomic inequalities in health of the Slovenian population measured by the EQ-5D instrument. In Norinder et al (2002).

    Google Scholar 

  • Rebolj M, Oppe S, Oppe M, Rabin R, Szende A, Cleemput I, de Charro F, Williams A. What light does EQ-5D shed on international differences in self-reported health problems by age, sex and educational level? In Macran and Kind (2002).

    Google Scholar 

  • Roset M, Badia X, Benavides A, Herdman M. The validity of the EQ-5D in children with asthma. In Badia et al (2000).

    Google Scholar 

  • Scalone L, Ciampichini R, Fagiuoli S, Gardini I, Gaeta L, Del Prete A, Magini G, Baldan A, Mantovani L. Comparing the standard EQ-5D-3L versus 5L version for the assessment of health of patients with liver diseases. In Yfantopoulos (2010).

    Google Scholar 

  • Scalone L and Mantovani L. (Eds.) 25th Scientific Plenary Meeting of the EuroQol Group Proceedings, Baveno, Italy, September 2008. EuroQol Group Executive Office, 2008.

    Google Scholar 

  • Secnik K, Matza L, Mannix S, Sallee F. Use of the EQ-5D proxy version in a sample of parents who have children diagnosed with attention deficit/ hyperactivity disorder (ADHD). In Prevolnik Rupel (2003).

    Google Scholar 

  • Selai C. The use of the EuroQol descriptive (pages 2 and 3) with patients at the Institute of Neurology, London. In O’Hanlon and Buxton (1995).

    Google Scholar 

  • Selai C and Rosser R. Eliciting EuroQol descriptive data and utility scale values from seriously ill in-patients: the pharmaco-economic relevance. In Busschbach et al (1994).

    Google Scholar 

  • Stavem K. (Ed.) 22nd Plenary Meeting of the EuroQol Group Discussion Papers, Oslo, Norway, September 2005. Helse-Øst Health Services Research Centre, Lørenskog, 2005.

    Google Scholar 

  • Stolk E and van Busschbach Jv. The performance of EuroQol in children. In Greiner et al (1999).

    Google Scholar 

  • Szanto Z and Susansky E. Quality of life and social inequalities in the middle aged Hungarian population: a population survey utilization of the EQ-5D. In Prevolnik Rupel (2003).

    Google Scholar 

  • Szende A. The (potential) role of the EQ-5D in the international comparison of socioeconomic inequalities in health status. In Macran and Kind (2002).

    Google Scholar 

  • Thompson S, Holtzer-Goor K, Schaafsma R, Uyl-de Groot C. Use of a 5-level EQ-5D instrument without additional labels in patients with chronic lymphocytic leukaemia. In Badia (2007).

    Google Scholar 

  • Tosh J, Brazier J, Evans P, Longworth L. A review of generic preference-based measures of health-related quality of life in visual disorders. Value in Health 2012; 15:118–27.

    Article  PubMed  Google Scholar 

  • Tsuchiya A, Brazier J, McColl E, Parkin D. A condition-specific instrument, a generic instrument, and a preference-based generic instrument. In Norinder et al (2002a).

    Google Scholar 

  • Yfantopoulos J, Papagianopoulou V, Rachiotis G, Bechrakis P. Socio-economic inequalities in health status and HRQOL among manual and non-manual workers in Greece. In Prevolnik Rupel (2003).

    Google Scholar 

  • Yfantopoulos J. (Ed.) 27th Scientific Plenary Meeting of the EuroQol Group Proceedings, Athens, Greece, September, 2010. EuroQol Group Executive Office, 2010.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. EuroQol Group, Rotterdam, The Netherlands

    Richard Brooks

Authors
  1. Richard Brooks
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Brooks, R. (2012). Applications. In: The EuroQol Group after 25 years. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5158-3_6

Download citation

Publish with us

Policies and ethics

Search

Navigation